Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritis

• Váldodahkkit: Cheng Chang (Dahkki), Camille Vong (Dahkki), Xiaoxing Wang (Dahkki), Anasuya Hazra (Dahkki), Annette Diehl (Dahkki), Timothy Nicholas (Dahkki), Arnab Mukherjee (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Wiley, 2024-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract These analyses characterized tofacitinib pharmacokinetics (PKs) in children and adolescents with juvenile idiopathic arthritis (JIA). Data were pooled from phase I (NCT01513902), phase III (NCT02592434), and open‐label, long‐term extension (NCT01500551) studies of tofacitinib tablet/solutio...